APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diabetic Retinopathy Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Diabetic Retinopathy Drugs Industry Growth and Trends Forecast to 2032

20 December 202598 pages

Choose your research edition.

Industry ResearchDiabetic Retinopathy Drugs Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Diabetic Retinopathy Drugs Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Diabetic Retinopathy Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diabetic Retinopathy Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Diabetic Retinopathy Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Diabetic Retinopathy Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Diabetic Retinopathy Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Diabetic Retinopathy Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Diabetic Retinopathy Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Diabetic Retinopathy Drugs include Novartis, Roche, Bayer Healthcare, Regeneron Pharmaceuticals, Neurotech Pharmaceuticals and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Diabetic Retinopathy Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Diabetic Retinopathy Drugs market size, estimates, and forecasts are presented in terms of sales volume (W Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Diabetic Retinopathy Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Diabetic Retinopathy Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Diabetic Retinopathy Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Diabetic Retinopathy Drugs Market by Company

Novartis

Roche

Bayer Healthcare

Regeneron Pharmaceuticals

Neurotech Pharmaceuticals

Allergan

Diabetic Retinopathy Drugs Segment by Type

Optina

Ozurdex

Betamethazone

Iluvien

Lucentis

Others

Diabetic Retinopathy Drugs Segment by Application

50-60 Years Old

60-70 Years Old

Others

Diabetic Retinopathy Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diabetic Retinopathy Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diabetic Retinopathy Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diabetic Retinopathy Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Diabetic Retinopathy Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Diabetic Retinopathy Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Optina Table 2. Major Company of Ozurdex Table 3. Major Company of Betamethazone Table 4. Major Company of Iluvien Table 5. Major Company of Lucentis Table 6. Major Company of Others Table 7. Global Diabetic Retinopathy Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Diabetic Retinopathy Drugs Sales by Type (2021-2026) & (W Tons) Table 9. Global Diabetic Retinopathy Drugs Sales Market Share in Volume by Type (2021-2026) Table 10. Global Diabetic Retinopathy Drugs Sales by Type (2021-2026) & (US$ Million) Table 11. Global Diabetic Retinopathy Drugs Sales Market Share in Value by Type (2021-2026) Table 12. Global Diabetic Retinopathy Drugs Price by Type (2021-2026) & (US$/Ton) Table 13. Global Diabetic Retinopathy Drugs Sales by Type (2027-2032) & (W Tons) Table 14. Global Diabetic Retinopathy Drugs Sales Market Share in Volume by Type (2027-2032) Table 15. Global Diabetic Retinopathy Drugs Sales by Type (2027-2032) & (US$ Million) Table 16. Global Diabetic Retinopathy Drugs Sales Market Share in Value by Type (2027-2032) Table 17. Global Diabetic Retinopathy Drugs Price by Type (2027-2032) & (US$/Ton) Table 18. North America Diabetic Retinopathy Drugs Sales by Type (2021-2026) & (W Tons) Table 19. North America Diabetic Retinopathy Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Diabetic Retinopathy Drugs Sales by Type (2021-2026) & (W Tons) Table 21. Europe Diabetic Retinopathy Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Diabetic Retinopathy Drugs Sales by Type (2021-2026) & (W Tons) Table 23. Asia-Pacific Diabetic Retinopathy Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Diabetic Retinopathy Drugs Sales by Type (2021-2026) & (W Tons) Table 25. Latin America Diabetic Retinopathy Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Diabetic Retinopathy Drugs Sales by Type (2021-2026) & (W Tons) Table 27. Middle East and Africa Diabetic Retinopathy Drugs Sales by Type (2021-2026) & (US$ Million) Table 28. Diabetic Retinopathy Drugs Industry Trends Table 29. Diabetic Retinopathy Drugs Industry Drivers Table 30. Diabetic Retinopathy Drugs Industry Opportunities and Challenges Table 31. Diabetic Retinopathy Drugs Industry Restraints Table 32. Global Diabetic Retinopathy Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Diabetic Retinopathy Drugs Revenue Market Share by Company (2021-2026) Table 34. Global Diabetic Retinopathy Drugs Sales by Company (2021-2026) & (W Tons) Table 35. Global Diabetic Retinopathy Drugs Sales Share by Company (2021-2026) Table 36. Global Diabetic Retinopathy Drugs Market Price by Company (2021-2026) & (US$/Ton) Table 37. Global Diabetic Retinopathy Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Diabetic Retinopathy Drugs Major Company Production Sites and Headquarters Table 39. Global Diabetic Retinopathy Drugs Company, Product Type & Application Table 40. Global Diabetic Retinopathy Drugs Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Diabetic Retinopathy Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Diabetic Retinopathy Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Diabetic Retinopathy Drugs Sales by Region (2021-2026) & (W Tons) Table 45. Global Diabetic Retinopathy Drugs Sales Market Share in Volume by Region (2021-2026) Table 46. Global Diabetic Retinopathy Drugs Sales by Region (2021-2026) & (US$ Million) Table 47. Global Diabetic Retinopathy Drugs Sales Market Share in Value by Region (2021-2026) Table 48. Global Diabetic Retinopathy Drugs Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 49. Global Diabetic Retinopathy Drugs Sales by Region (2027-2032) & (W Tons) Table 50. Global Diabetic Retinopathy Drugs Sales Market Share in Volume by Region (2027-2032) Table 51. Global Diabetic Retinopathy Drugs Sales by Region (2027-2032) & (US$ Million) Table 52. Global Diabetic Retinopathy Drugs Sales Market Share in Value by Region (2027-2032) Table 53. Global Diabetic Retinopathy Drugs Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 54. Global Diabetic Retinopathy Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Diabetic Retinopathy Drugs Sales by Application (2021-2026) & (W Tons) Table 56. Global Diabetic Retinopathy Drugs Sales Market Share in Volume by Application (2021-2026) Table 57. Global Diabetic Retinopathy Drugs Sales by Application (2021-2026) & (US$ Million) Table 58. Global Diabetic Retinopathy Drugs Sales Market Share in Value by Application (2021-2026) Table 59. Global Diabetic Retinopathy Drugs Price by Application (2021-2026) & (US$/Ton) Table 60. Global Diabetic Retinopathy Drugs Sales by Application (2027-2032) & (W Tons) Table 61. Global Diabetic Retinopathy Drugs Sales Market Share in Volume by Application (2027-2032) Table 62. Global Diabetic Retinopathy Drugs Sales by Application (2027-2032) & (US$ Million) Table 63. Global Diabetic Retinopathy Drugs Sales Market Share in Value by Application (2027-2032) Table 64. Global Diabetic Retinopathy Drugs Price by Application (2027-2032) & (US$/Ton) Table 65. North America Diabetic Retinopathy Drugs Sales by Application (2021-2026) & (W Tons) Table 66. North America Diabetic Retinopathy Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Diabetic Retinopathy Drugs Sales by Application (2021-2026) & (W Tons) Table 68. Europe Diabetic Retinopathy Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Diabetic Retinopathy Drugs Sales by Application (2021-2026) & (W Tons) Table 70. Asia-Pacific Diabetic Retinopathy Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Diabetic Retinopathy Drugs Sales by Application (2021-2026) & (W Tons) Table 72. Latin America Diabetic Retinopathy Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Diabetic Retinopathy Drugs Sales by Application (2021-2026) & (W Tons) Table 74. Middle East and Africa Diabetic Retinopathy Drugs Sales by Application (2021-2026) & (US$ Million) Table 75. Novartis Company Information Table 76. Novartis Business Overview Table 77. Novartis Diabetic Retinopathy Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Novartis Diabetic Retinopathy Drugs Product Portfolio Table 79. Novartis Recent Development Table 80. Roche Company Information Table 81. Roche Business Overview Table 82. Roche Diabetic Retinopathy Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Roche Diabetic Retinopathy Drugs Product Portfolio Table 84. Roche Recent Development Table 85. Bayer Healthcare Company Information Table 86. Bayer Healthcare Business Overview Table 87. Bayer Healthcare Diabetic Retinopathy Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Bayer Healthcare Diabetic Retinopathy Drugs Product Portfolio Table 89. Bayer Healthcare Recent Development Table 90. Regeneron Pharmaceuticals Company Information Table 91. Regeneron Pharmaceuticals Business Overview Table 92. Regeneron Pharmaceuticals Diabetic Retinopathy Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Regeneron Pharmaceuticals Diabetic Retinopathy Drugs Product Portfolio Table 94. Regeneron Pharmaceuticals Recent Development Table 95. Neurotech Pharmaceuticals Company Information Table 96. Neurotech Pharmaceuticals Business Overview Table 97. Neurotech Pharmaceuticals Diabetic Retinopathy Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Neurotech Pharmaceuticals Diabetic Retinopathy Drugs Product Portfolio Table 99. Neurotech Pharmaceuticals Recent Development Table 100. Allergan Company Information Table 101. Allergan Business Overview Table 102. Allergan Diabetic Retinopathy Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. Allergan Diabetic Retinopathy Drugs Product Portfolio Table 104. Allergan Recent Development Table 105. North America Diabetic Retinopathy Drugs Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 106. North America Diabetic Retinopathy Drugs Sales by Country (2021-2026) & (W Tons) Table 107. North America Diabetic Retinopathy Drugs Sales Market Share by Country (2021-2026) Table 108. North America Diabetic Retinopathy Drugs Sales Forecast by Country (2027-2032) & (W Tons) Table 109. North America Diabetic Retinopathy Drugs Sales Market Share Forecast by Country (2027-2032) Table 110. North America Diabetic Retinopathy Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 111. North America Diabetic Retinopathy Drugs Market Size by Country (2021-2026) & (US$ Million) Table 112. North America Diabetic Retinopathy Drugs Market Share by Country (2021-2026) Table 113. North America Diabetic Retinopathy Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 114. North America Diabetic Retinopathy Drugs Market Share Forecast by Country (2027-2032) Table 115. Europe Diabetic Retinopathy Drugs Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 116. Europe Diabetic Retinopathy Drugs Sales by Country (2021-2026) & (W Tons) Table 117. Europe Diabetic Retinopathy Drugs Sales Market Share by Country (2021-2026) Table 118. Europe Diabetic Retinopathy Drugs Sales Forecast by Country (2027-2032) & (W Tons) Table 119. Europe Diabetic Retinopathy Drugs Sales Market Share Forecast by Country (2027-2032) Table 120. Europe Diabetic Retinopathy Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 121. Europe Diabetic Retinopathy Drugs Market Size by Country (2021-2026) & (US$ Million) Table 122. Europe Diabetic Retinopathy Drugs Market Share by Country (2021-2026) Table 123. Europe Diabetic Retinopathy Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 124. Europe Diabetic Retinopathy Drugs Market Share Forecast by Country (2027-2032) Table 125. Asia-Pacific Diabetic Retinopathy Drugs Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 126. Asia-Pacific Diabetic Retinopathy Drugs Sales by Country (2021-2026) & (W Tons) Table 127. Asia-Pacific Diabetic Retinopathy Drugs Sales Market Share by Country (2021-2026) Table 128. Asia-Pacific Diabetic Retinopathy Drugs Sales Forecast by Country (2027-2032) & (W Tons) Table 129. Asia-Pacific Diabetic Retinopathy Drugs Sales Market Share Forecast by Country (2027-2032) Table 130. Asia-Pacific Diabetic Retinopathy Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. Asia-Pacific Diabetic Retinopathy Drugs Market Size by Country (2021-2026) & (US$ Million) Table 132. Asia-Pacific Diabetic Retinopathy Drugs Market Share by Country (2021-2026) Table 133. Asia-Pacific Diabetic Retinopathy Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. Asia-Pacific Diabetic Retinopathy Drugs Market Share Forecast by Country (2027-2032) Table 135. Latin America Diabetic Retinopathy Drugs Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 136. Latin America Diabetic Retinopathy Drugs Sales by Country (2021-2026) & (W Tons) Table 137. Latin America Diabetic Retinopathy Drugs Sales Market Share by Country (2021-2026) Table 138. Latin America Diabetic Retinopathy Drugs Sales Forecast by Country (2027-2032) & (W Tons) Table 139. Latin America Diabetic Retinopathy Drugs Sales Market Share Forecast by Country (2027-2032) Table 140. Latin America Diabetic Retinopathy Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Latin America Diabetic Retinopathy Drugs Market Size by Country (2021-2026) & (US$ Million) Table 142. Latin America Diabetic Retinopathy Drugs Market Share by Country (2021-2026) Table 143. Latin America Diabetic Retinopathy Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Latin America Diabetic Retinopathy Drugs Market Share Forecast by Country (2027-2032) Table 145. Middle East and Africa Diabetic Retinopathy Drugs Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 146. Middle East and Africa Diabetic Retinopathy Drugs Sales by Country (2021-2026) & (W Tons) Table 147. Middle East and Africa Diabetic Retinopathy Drugs Sales Market Share by Country (2021-2026) Table 148. Middle East and Africa Diabetic Retinopathy Drugs Sales Forecast by Country (2027-2032) & (W Tons) Table 149. Middle East and Africa Diabetic Retinopathy Drugs Sales Market Share Forecast by Country (2027-2032) Table 150. Middle East and Africa Diabetic Retinopathy Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Middle East and Africa Diabetic Retinopathy Drugs Market Size by Country (2021-2026) & (US$ Million) Table 152. Middle East and Africa Diabetic Retinopathy Drugs Market Share by Country (2021-2026) Table 153. Middle East and Africa Diabetic Retinopathy Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Middle East and Africa Diabetic Retinopathy Drugs Market Share Forecast by Country (2027-2032) Table 155. Key Raw Materials Table 156. Raw Materials Key Suppliers Table 157. Diabetic Retinopathy Drugs Distributors List Table 158. Diabetic Retinopathy Drugs Customers List Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Diabetic Retinopathy Drugs Image Figure 2. Global Diabetic Retinopathy Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diabetic Retinopathy Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Diabetic Retinopathy Drugs Sales (2021-2032) & (W Tons) Figure 5. Optina Image Figure 6. Global Optina Sales YoY Growth (2021-2032) & (W Tons) Figure 7. Ozurdex Image Figure 8. Global Ozurdex Sales YoY Growth (2021-2032) & (W Tons) Figure 9. Betamethazone Image Figure 10. Global Betamethazone Sales YoY Growth (2021-2032) & (W Tons) Figure 11. Iluvien Image Figure 12. Global Iluvien Sales YoY Growth (2021-2032) & (W Tons) Figure 13. Lucentis Image Figure 14. Global Lucentis Sales YoY Growth (2021-2032) & (W Tons) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (W Tons) Figure 17. Global Diabetic Retinopathy Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Diabetic Retinopathy Drugs Market Share by Type 2025 VS 2032 Figure 19. North America Diabetic Retinopathy Drugs Sales Market Share in Volume by Type in 2025 Figure 20. North America Diabetic Retinopathy Drugs Sales Market Share in Value by Type in 2025 Figure 21. Europe Diabetic Retinopathy Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Europe Diabetic Retinopathy Drugs Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Diabetic Retinopathy Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Diabetic Retinopathy Drugs Sales Market Share in Value by Type in 2025 Figure 25. Latin America Diabetic Retinopathy Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Diabetic Retinopathy Drugs Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Diabetic Retinopathy Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Diabetic Retinopathy Drugs Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Diabetic Retinopathy Drugs Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. 50-60 Years Old Image Figure 32. Global 50-60 Years Old Sales YoY Growth (2021-2032) & (W Tons) Figure 33. 60-70 Years Old Image Figure 34. Global 60-70 Years Old Sales YoY Growth (2021-2032) & (W Tons) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (W Tons) Figure 37. Global Diabetic Retinopathy Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Diabetic Retinopathy Drugs Market Share by Application 2025 VS 2032 Figure 39. North America Diabetic Retinopathy Drugs Sales Market Share in Volume by Application in 2025 Figure 40. North America Diabetic Retinopathy Drugs Sales Market Share in Value by Application in 2025 Figure 41. Europe Diabetic Retinopathy Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Europe Diabetic Retinopathy Drugs Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Diabetic Retinopathy Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Diabetic Retinopathy Drugs Sales Market Share in Value by Application in 2025 Figure 45. Latin America Diabetic Retinopathy Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Diabetic Retinopathy Drugs Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Diabetic Retinopathy Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Diabetic Retinopathy Drugs Sales Market Share in Value by Application in 2025 Figure 49. North America Diabetic Retinopathy Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 50. North America Diabetic Retinopathy Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Diabetic Retinopathy Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Diabetic Retinopathy Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Diabetic Retinopathy Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 54. Europe Diabetic Retinopathy Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Diabetic Retinopathy Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Diabetic Retinopathy Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Diabetic Retinopathy Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 58. Asia-Pacific Diabetic Retinopathy Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Diabetic Retinopathy Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Diabetic Retinopathy Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Diabetic Retinopathy Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 62. Latin America Diabetic Retinopathy Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Diabetic Retinopathy Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Diabetic Retinopathy Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Diabetic Retinopathy Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 66. Middle East and Africa Diabetic Retinopathy Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Diabetic Retinopathy Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Diabetic Retinopathy Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Diabetic Retinopathy Drugs Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Diabetic Retinopathy Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Optina
  • Ozurdex
  • Betamethazone
  • Iluvien
  • Lucentis
  • Others
Applications
  • 50-60 Years Old
  • 60-70 Years Old
  • Others
Companies covered
  • Novartis
  • Roche
  • Bayer Healthcare
  • Regeneron Pharmaceuticals
  • Neurotech Pharmaceuticals
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Diabetic Retinopathy Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Diabetic Retinopathy Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Diabetic Retinopathy Drugs Market by Type
  6. 1.3.1 Optina
  7. 1.3.2 Ozurdex
  8. 1.3.3 Betamethazone
  9. 1.3.4 Iluvien
  10. 1.3.5 Lucentis
  11. 1.3.6 Others
  12. 1.4 Global Diabetic Retinopathy Drugs Market Size by Type
  13. 1.4.1 Global Diabetic Retinopathy Drugs Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Diabetic Retinopathy Drugs Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Diabetic Retinopathy Drugs Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Diabetic Retinopathy Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Diabetic Retinopathy Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Diabetic Retinopathy Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Diabetic Retinopathy Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Diabetic Retinopathy Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Diabetic Retinopathy Drugs Industry Trends
  2. 2.2 Diabetic Retinopathy Drugs Industry Drivers
  3. 2.3 Diabetic Retinopathy Drugs Industry Opportunities and Challenges
  4. 2.4 Diabetic Retinopathy Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Diabetic Retinopathy Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Diabetic Retinopathy Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Diabetic Retinopathy Drugs Price (2021-2026)
  4. 3.4 Global Diabetic Retinopathy Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Diabetic Retinopathy Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Diabetic Retinopathy Drugs Company, Product Type & Application
  7. 3.7 Global Diabetic Retinopathy Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Diabetic Retinopathy Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Diabetic Retinopathy Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Diabetic Retinopathy Drugs Tier 1, Tier 2, and Tier 3
4 Diabetic Retinopathy Drugs Regional Status and Outlook
  1. 4.1 Global Diabetic Retinopathy Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Diabetic Retinopathy Drugs Historic Market Size by Region
  3. 4.2.1 Global Diabetic Retinopathy Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Diabetic Retinopathy Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Diabetic Retinopathy Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Diabetic Retinopathy Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Diabetic Retinopathy Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Diabetic Retinopathy Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Diabetic Retinopathy Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Diabetic Retinopathy Drugs by Application
  1. 5.1 Diabetic Retinopathy Drugs Market by Application
  2. 5.1.1 50-60 Years Old
  3. 5.1.2 60-70 Years Old
  4. 5.1.3 Others
  5. 5.2 Global Diabetic Retinopathy Drugs Market Size by Application
  6. 5.2.1 Global Diabetic Retinopathy Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Diabetic Retinopathy Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Diabetic Retinopathy Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Diabetic Retinopathy Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Diabetic Retinopathy Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Diabetic Retinopathy Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Diabetic Retinopathy Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Diabetic Retinopathy Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Diabetic Retinopathy Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Diabetic Retinopathy Drugs Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche Diabetic Retinopathy Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Roche Diabetic Retinopathy Drugs Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 Bayer Healthcare
  14. 6.3.1 Bayer Healthcare Company Information
  15. 6.3.2 Bayer Healthcare Business Overview
  16. 6.3.3 Bayer Healthcare Diabetic Retinopathy Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bayer Healthcare Diabetic Retinopathy Drugs Product Portfolio
  18. 6.3.5 Bayer Healthcare Recent Developments
  19. 6.4 Regeneron Pharmaceuticals
  20. 6.4.1 Regeneron Pharmaceuticals Company Information
  21. 6.4.2 Regeneron Pharmaceuticals Business Overview
  22. 6.4.3 Regeneron Pharmaceuticals Diabetic Retinopathy Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Regeneron Pharmaceuticals Diabetic Retinopathy Drugs Product Portfolio
  24. 6.4.5 Regeneron Pharmaceuticals Recent Developments
  25. 6.5 Neurotech Pharmaceuticals
  26. 6.5.1 Neurotech Pharmaceuticals Company Information
  27. 6.5.2 Neurotech Pharmaceuticals Business Overview
  28. 6.5.3 Neurotech Pharmaceuticals Diabetic Retinopathy Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Neurotech Pharmaceuticals Diabetic Retinopathy Drugs Product Portfolio
  30. 6.5.5 Neurotech Pharmaceuticals Recent Developments
  31. 6.6 Allergan
  32. 6.6.1 Allergan Company Information
  33. 6.6.2 Allergan Business Overview
  34. 6.6.3 Allergan Diabetic Retinopathy Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Allergan Diabetic Retinopathy Drugs Product Portfolio
  36. 6.6.5 Allergan Recent Developments
7 North America by Country
  1. 7.1 North America Diabetic Retinopathy Drugs Sales by Country
  2. 7.1.1 North America Diabetic Retinopathy Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Diabetic Retinopathy Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Diabetic Retinopathy Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Diabetic Retinopathy Drugs Market Size by Country
  6. 7.2.1 North America Diabetic Retinopathy Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Diabetic Retinopathy Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Diabetic Retinopathy Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Diabetic Retinopathy Drugs Sales by Country
  2. 8.1.1 Europe Diabetic Retinopathy Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Diabetic Retinopathy Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Diabetic Retinopathy Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Diabetic Retinopathy Drugs Market Size by Country
  6. 8.2.1 Europe Diabetic Retinopathy Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Diabetic Retinopathy Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Diabetic Retinopathy Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Diabetic Retinopathy Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Diabetic Retinopathy Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Diabetic Retinopathy Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Diabetic Retinopathy Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Diabetic Retinopathy Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Diabetic Retinopathy Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Diabetic Retinopathy Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Diabetic Retinopathy Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Diabetic Retinopathy Drugs Sales by Country
  2. 10.1.1 South America Diabetic Retinopathy Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Diabetic Retinopathy Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Diabetic Retinopathy Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Diabetic Retinopathy Drugs Market Size by Country
  6. 10.2.1 South America Diabetic Retinopathy Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Diabetic Retinopathy Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Diabetic Retinopathy Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Diabetic Retinopathy Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Diabetic Retinopathy Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Diabetic Retinopathy Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Diabetic Retinopathy Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Diabetic Retinopathy Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Diabetic Retinopathy Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Diabetic Retinopathy Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Diabetic Retinopathy Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Diabetic Retinopathy Drugs Value Chain Analysis
  2. 12.1.1 Diabetic Retinopathy Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Diabetic Retinopathy Drugs Production Mode & Process
  7. 12.2 Diabetic Retinopathy Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Diabetic Retinopathy Drugs Distributors
  10. 12.2.3 Diabetic Retinopathy Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst